Benefitfocus, Inc. (NASDAQ:
BNFT), an industry-leading cloud-based benefits
administration technology company that simplifies benefits
administration for employers, health plans and brokers, today
announces its second quarter 2022 financial
results:
Financial Highlights for the Second Quarter
2022:
- Revenue of $56.6 million was at the high end of the guidance
range of $55 to $57 million.
- Adjusted EBITDA of $6.2 million was above the high end of the
guidance range of $4 to $6 million.
- GAAP net loss available to common stockholders was ($13.8)
million, compared to ($16.6) million in the second quarter of
2021.
- GAAP EPS was ($0.40) in the second quarter of 2022 and non-GAAP
EPS was ($0.10).
Operational Highlights for the Second
Quarter 2022:
- Launched a new product called Claims Audit & Recovery
Services, which is designed to analyze claims data to identify
errors and waste, and seek reimbursement.
- Entered into a strategic sales partnership with Lockton,
expected to drive further penetration into the employer
segment.
- Appointed Ed Rumzis as our new Chief Technology Officer
starting on August 8, adding another seasoned industry veteran to
the leadership team.
“During the second quarter, the team continued
to demonstrate a high say:do ratio against our three-pillar
transformation plan.” said Benefitfocus President and Chief
Executive Officer, Matt Levin. “We are establishing relationships
with key players in the ecosystem and seeing early indicators that
our go-to-market strategy is working, both a testament to our
unwavering focus on service excellence.”
“We were once again able to deliver financial results at or
better than our guidance ranges for this quarter,” said Alpana
Wegner, Chief Financial Officer. “We are pleased with the progress
we are making on executing our strategy to drive sustainable growth
and are well-positioned to unlock long-term value for our
shareholders.”
Second Quarter 2022 Financial
Highlights Revenue
- Total revenue was $56.6 million,
down approximately 7% compared to the second quarter of 2021.
- Software services, which is
comprised of both subscription and platform revenue, was $48.6
million, down 3% compared to the second quarter of 2021.
- Subscription revenue was $42.0
million, down 5% compared to the second quarter of 2021.
- Platform revenue was $6.6 million,
up 12% compared to the second quarter of 2021.
- Professional services revenue was
$8.0 million, down 25% compared to the second quarter of 2021.
Net Loss
- GAAP net loss was ($12.2) million,
compared to ($15.0) million in the second quarter of 2021. GAAP net
loss per share was ($0.40), based on ($13.8) million net loss
available to common stockholders and 34.0 million basic and diluted
weighted average common shares outstanding. This compares to GAAP
net loss per share of ($0.50) for the second quarter of 2021, based
on ($16.6) million net loss available to common stockholders and
33.1 million basic and diluted weighted average common shares
outstanding.
Non-GAAP Net Loss, Adjusted EBITDA and
Free Cash Flow
- Non-GAAP net loss available to
common stockholders was ($3.5) million for the second quarter of
2022, compared to ($5.9) million in the second quarter of 2021.
Non-GAAP net loss per share was ($0.10) based on both 34.0 million
basic and diluted weighted average common shares outstanding. This
compares to non-GAAP net loss of ($0.18) in the second quarter of
2021, based on both 33.1 million basic and diluted weighted average
common shares outstanding.
- Adjusted EBITDA was $6.2 million,
compared to $9.6 million in the second quarter of
2021.
- Cash used in operations was ($0.7)
million and free cash flow was ($2.1) million, compared to cash
from operations of $9.2 million and $6.6 million of free cash flow
in the second quarter of 2021.
See important disclosures about non-GAAP
measures, and a reconciliation of them to GAAP, below.
Balance Sheet Cash and cash
equivalents at June 30, 2022, totaled $51.5 million, compared to
cash and cash equivalents and marketable securities of $68.1
million at the end of the of 2021, a decline driven by the timing
of working capital changes.
The full $50.0 million line of credit remains
available to the company.
Business OutlookBenefitfocus is
providing guidance for the third quarter and full year 2022 as
indicated below.
Third Quarter 2022
- Total revenue is expected to be in
the range of $55 million to $57 million.
- Adjusted EBITDA is expected to be
in the range of $4 million to $6 million.
- Non-GAAP net loss available to
common stockholders is expected to be between ($6.0) million and
($4.0) million, or between ($0.18) and ($0.12) per share based on
34.0 million basic and diluted weighted average shares
outstanding.
Full-Year 2022
- Total revenue is expected to be in
the range of $252 million to $258 million.
- Adjusted EBITDA is expected to be
in the range of $44 million to $50 million.
- Free cash flow is expected to be in
the range of $18 million to $24 million.
Adjusted EBITDA and free cash flow guidance
excludes the impact of restructuring and impairment charges.
Management has not reconciled forward-looking
non-GAAP net loss, adjusted EBITDA or free cash flow to their most
directly comparable GAAP measure of GAAP net loss or GAAP operating
cash flows. This is because we cannot predict with reasonable
certainty the ultimate outcome of the various necessary GAAP
components of such reconciliations, including, for example, those
related to certain impairment charges, acquisition transactions and
integration, costs not core to our business or others that may
arise during the year, without unreasonable effort. These
components and other factors could materially impact the amount of
future directly comparable GAAP measures, which may differ
significantly from their non-GAAP counterparts. See below for
additional important disclosures regarding our non-GAAP financial
measures.
Conference Call Details:In
conjunction with this announcement, Benefitfocus will
host a conference call to discuss the company’s financial results
and business outlook on Wednesday, August 3, 2022,
at 5:00 p.m. ET. To access this call, dial (800) 941-4658
(domestic) or +1 (416) 981-9033 (international). A live webcast of
the conference call will be available on the Investor Relations
page of the company’s website
at http://investor.benefitfocus.com/. After the conference
call, a replay will be available until August 10, 2022, at
11:59 p.m. ET and can be accessed by dialing (844) 512-2921
(domestic) or +1 (412) 317-6671 (international) with passcode
22019867.
About
BenefitfocusBenefitfocus (NASDAQ: BNFT) is a
cloud-based benefits administration technology company committed to
helping our customers, and the people they serve, get the most out
of their health care and benefit programs. Through exceptional
service and innovative SaaS solutions, we aim to be the safest set
of hands for our customers helping to simplify the complexity of
benefits administration while delivering an experience that engages
people and unlocks the potential for better health and improved
outcomes. Our mission is simple: to improve lives with
benefits.
Non-GAAP Financial MeasuresThe
company uses certain non-GAAP financial measures in this release,
including non-GAAP gross profit, operating income/loss, net
loss/income, net loss/income per common share, adjusted EBITDA and
free cash flow. Generally, a non-GAAP financial measure is a
numerical measure of a company’s performance or financial position
that either excludes or includes amounts that are not normally
excluded or included in the most directly comparable measure
calculated and presented in accordance with GAAP.
Non-GAAP gross profit, operating income/loss,
net loss/income and net loss/income per common share exclude
stock-based compensation expenses, amortization of
acquisition-related intangible assets, transaction and
acquisition-related costs expensed, expense related to the
impairment of goodwill, intangible assets and long-lived assets,
gain or loss on extinguishment of debt, change in fair value of
contingently returnable consideration and costs not core to our
business. We define adjusted EBITDA as net loss before net
interest, taxes, and depreciation and amortization expense,
adjusted to eliminate stock-based compensation expense; transaction
and acquisition-related costs expensed; restructuring costs;
impairment of goodwill, intangible assets and long-lived assets;
gain or loss on extinguishment of debt; other costs not core to our
business; loss on settlement of lawsuits; and, now, changes in fair
value of contingently returnable consideration. The revision to our
definition of adjusted EBITDA had no impact on our reported
adjusted EBITDA in prior periods. We define free cash flow as cash
provided by or used in operating activities less capital
expenditures, adjusted to eliminate cash paid for restructuring
costs. Please note that other companies might define their non-GAAP
financial measures differently than we do.
Management presents these non-GAAP
financial measures in this release because it considers them to be
important supplemental measures of performance. Management uses
these non-GAAP financial measures for planning purposes, including
analysis of the company's performance against prior periods, the
preparation of operating budgets and to determine appropriate
levels of operating and capital investments. Management believes
that these non-GAAP financial measures provide additional insight
for analysts and investors in evaluating the company's financial
and operational performance. Management also intends to provide
these non-GAAP financial measures as part of the company’s future
earnings discussions and, therefore, their inclusion should provide
consistency in the company’s financial reporting.
Non-GAAP financial measures have limitations as
an analytical tool. Investors are encouraged to review the
reconciliation of the non-GAAP measures to their most directly
comparable GAAP measures provided in this release, including in the
accompanying tables.
Safe Harbor StatementExcept for
historical information, all of the statements, expectations, and
assumptions contained in this press release are forward-looking
statements. Actual results might differ materially from those
explicit or implicit in the forward-looking statements. Important
factors that could cause actual results to differ materially
include: our need to increase sales and achieve consistent GAAP
profitability; fluctuations in our financial results; our ability
to maintain our culture and recruit, integrate and retain qualified
personnel, including on our board of directors; our ability to
compete effectively and implement our growth strategy; our reliance
on channel relationships; market developments and opportunities;
the need to innovate and provide useful products and services;
risks related to changing healthcare and other applicable
regulations; the immature and volatile nature of the market for our
products and services; privacy; security and other risks associated
with our business; management of growth; volatility and uncertainty
in the global economy and financial markets in light of the
evolving COVID-19 pandemic and war in Ukraine; and the other risk
factors set forth from time to time in our SEC filings, copies of
which are available free of charge within the Investor Relations
section of the Benefitfocus website at
http://investor.benefitfocus.com/sec-filings or upon request from
our Investor Relations Department. Benefitfocus assumes no
obligation and does not intend to update these forward-looking
statements, except as required by law.
Source: Benefitfocus, Inc.
Media Contact:843-981-8898pr@benefitfocus.com
Investor Relations:Doug
Kuckelman843-790-7460ir@benefitfocus.com
|
|
Benefitfocus, Inc.Unaudited Consolidated
Statements of Operations and Comprehensive Loss(in
thousands, except share and per share data) |
|
|
|
|
|
Three Months EndedJune 30, |
|
|
Six Months EndedJune 30, |
|
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
Revenue |
|
$ |
56,587 |
|
|
$ |
60,904 |
|
|
$ |
117,812 |
|
|
$ |
125,967 |
|
Cost of
revenue(1)(2) |
|
|
29,095 |
|
|
|
28,030 |
|
|
|
58,981 |
|
|
|
56,623 |
|
Gross
profit |
|
|
27,492 |
|
|
|
32,874 |
|
|
|
58,831 |
|
|
|
69,344 |
|
Operating expenses:(1)(2)(3) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing |
|
|
10,643 |
|
|
|
10,921 |
|
|
|
20,567 |
|
|
|
21,812 |
|
Research and development |
|
|
12,249 |
|
|
|
11,103 |
|
|
|
23,406 |
|
|
|
21,935 |
|
General and administrative |
|
|
13,517 |
|
|
|
13,571 |
|
|
|
22,806 |
|
|
|
23,433 |
|
Impairment of lease right-of-use assets |
|
|
1,769 |
|
|
|
4,003 |
|
|
|
1,769 |
|
|
|
4,003 |
|
Change in fair value of contingently returnable consideration |
|
|
(719 |
) |
|
|
– |
|
|
|
(719 |
) |
|
|
– |
|
Restructuring costs |
|
|
– |
|
|
|
2,727 |
|
|
|
1,006 |
|
|
|
4,127 |
|
Total operating expenses |
|
|
37,459 |
|
|
|
42,325 |
|
|
|
68,835 |
|
|
|
75,310 |
|
Loss
from operations |
|
|
(9,967 |
) |
|
|
(9,451 |
) |
|
|
(10,004 |
) |
|
|
(5,966 |
) |
Other
income (expense): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income |
|
|
72 |
|
|
|
54 |
|
|
|
84 |
|
|
|
111 |
|
Interest expense |
|
|
(2,476 |
) |
|
|
(5,646 |
) |
|
|
(4,958 |
) |
|
|
(11,201 |
) |
Other income |
|
|
236 |
|
|
|
64 |
|
|
|
482 |
|
|
|
22 |
|
Total other expense, net |
|
|
(2,168 |
) |
|
|
(5,528 |
) |
|
|
(4,392 |
) |
|
|
(11,068 |
) |
Loss
before income taxes |
|
|
(12,135 |
) |
|
|
(14,979 |
) |
|
|
(14,396 |
) |
|
|
(17,034 |
) |
Income
tax expense |
|
|
29 |
|
|
|
41 |
|
|
|
45 |
|
|
|
83 |
|
Net
loss |
|
|
(12,164 |
) |
|
|
(15,020 |
) |
|
|
(14,441 |
) |
|
|
(17,117 |
) |
Preferred dividends |
|
|
(1,600 |
) |
|
|
(1,600 |
) |
|
|
(3,200 |
) |
|
|
(3,200 |
) |
Net loss
available to common stockholders |
|
$ |
(13,764 |
) |
|
$ |
(16,620 |
) |
|
$ |
(17,641 |
) |
|
$ |
(20,317 |
) |
Comprehensive loss |
|
$ |
(12,164 |
) |
|
$ |
(15,020 |
) |
|
$ |
(14,441 |
) |
|
$ |
(17,117 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
per common share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted |
|
$ |
(0.40 |
) |
|
$ |
(0.50 |
) |
|
$ |
(0.52 |
) |
|
$ |
(0.62 |
) |
Weighted-average common shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted |
|
|
34,028,422 |
|
|
|
33,080,257 |
|
|
|
33,764,103 |
|
|
|
32,787,162 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
Stock-based compensation included in above line items: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of revenue |
|
$ |
1,008 |
|
|
$ |
638 |
|
|
$ |
1,204 |
|
|
$ |
964 |
|
Sales and marketing |
|
|
1,110 |
|
|
|
927 |
|
|
|
1,746 |
|
|
|
1,507 |
|
Research and development |
|
|
783 |
|
|
|
503 |
|
|
|
1,014 |
|
|
|
621 |
|
General and administrative |
|
|
2,414 |
|
|
|
2,308 |
|
|
|
2,540 |
|
|
|
2,807 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2)
Amortization of acquired intangible assets included in above line
items: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of revenue |
|
$ |
610 |
|
|
$ |
336 |
|
|
$ |
1,232 |
|
|
$ |
673 |
|
Sales and marketing |
|
|
131 |
|
|
|
77 |
|
|
|
273 |
|
|
|
153 |
|
Research and development |
|
|
233 |
|
|
|
113 |
|
|
|
449 |
|
|
|
226 |
|
General and administrative |
|
|
99 |
|
|
|
43 |
|
|
|
192 |
|
|
|
85 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3)
Transaction and acquisition-related costs expensed included in
above line items: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General and administrative |
|
$ |
13 |
|
|
$ |
6 |
|
|
$ |
96 |
|
|
$ |
160 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefitfocus, Inc.Unaudited Consolidated Balance
Sheets(in thousands, except share and per share data) |
|
|
|
|
|
As ofJune
30,2022 |
|
|
As ofDecember
31,2021 |
|
Assets |
|
|
|
|
|
|
|
|
Current
assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
51,497 |
|
|
$ |
31,001 |
|
Marketable securities |
|
|
– |
|
|
|
37,049 |
|
Accounts receivable, net |
|
|
22,342 |
|
|
|
16,491 |
|
Contract, prepaid and other current assets |
|
|
33,558 |
|
|
|
27,615 |
|
Total current assets |
|
|
107,397 |
|
|
|
112,156 |
|
Property
and equipment, net |
|
|
26,048 |
|
|
|
27,202 |
|
Financing lease right-of-use assets |
|
|
50,391 |
|
|
|
56,474 |
|
Operating lease right-of-use assets |
|
|
669 |
|
|
|
774 |
|
Intangible assets, net |
|
|
18,988 |
|
|
|
21,134 |
|
Goodwill |
|
|
34,237 |
|
|
|
34,237 |
|
Deferred
contract costs and other non-current assets |
|
|
7,283 |
|
|
|
8,864 |
|
Total assets |
|
$ |
245,013 |
|
|
$ |
260,841 |
|
Liabilities, redeemable preferred stock and stockholders'
deficit |
|
|
|
|
|
|
|
|
Current
liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
5,298 |
|
|
$ |
10,565 |
|
Accrued expenses |
|
|
17,546 |
|
|
|
9,451 |
|
Accrued compensation and benefits |
|
|
11,557 |
|
|
|
16,411 |
|
Deferred revenue, current portion |
|
|
27,808 |
|
|
|
27,756 |
|
Lease liabilities and financing obligations, current portion |
|
|
6,387 |
|
|
|
7,378 |
|
Contingent consideration |
|
|
– |
|
|
|
675 |
|
Total current liabilities |
|
|
68,596 |
|
|
|
72,236 |
|
Deferred
revenue, net of current portion |
|
|
2,464 |
|
|
|
2,377 |
|
Convertible senior notes |
|
|
119,962 |
|
|
|
107,281 |
|
Lease
liabilities and financing obligations, net current portion |
|
|
74,184 |
|
|
|
75,758 |
|
Other
non-current liabilities |
|
|
372 |
|
|
|
313 |
|
Total liabilities |
|
|
265,578 |
|
|
|
257,965 |
|
Commitments and contingencies |
|
|
|
|
|
|
|
|
Redeemable preferred stock: |
|
|
|
|
|
|
|
|
Series A preferred stock, par value $0.001, 5,000,000 shares
authorized, 1,777,778 and 1,777,778 shares issued and
outstanding at June 30, 2022 and December 31, 2021,
respectively, liquidation preference $45 per share as of June
30, 2022 and December 31, 2021, respectively |
|
|
79,193 |
|
|
|
79,193 |
|
Stockholders' deficit: |
|
|
|
|
|
|
|
|
Common stock, par value $0.001, 95,000,000 shares authorized,
34,172,079 and 33,460,545 issued and outstanding at June 30, 2022
and December 31, 2021, respectively |
|
|
34 |
|
|
|
33 |
|
Additional paid-in capital |
|
|
382,204 |
|
|
|
431,874 |
|
Accumulated deficit |
|
|
(481,996 |
) |
|
|
(508,224 |
) |
Total stockholders' deficit |
|
|
(99,758 |
) |
|
|
(76,317 |
) |
Total liabilities, redeemable preferred stock
and stockholders' deficit |
|
$ |
245,013 |
|
|
$ |
260,841 |
|
|
|
|
|
|
|
|
|
|
Benefitfocus, Inc.Unaudited Consolidated
Statements of Cash Flows(in thousands) |
|
|
|
|
|
Six Months EndedJune 30, |
|
|
|
2022 |
|
|
2021 |
|
Cash flows from operating activities |
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(14,441 |
) |
|
$ |
(17,117 |
) |
Adjustments to reconcile net loss to net cash (used in) provided by
operating activities: |
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
13,462 |
|
|
|
12,525 |
|
Stock-based compensation expense |
|
|
6,504 |
|
|
|
5,899 |
|
Accretion of interest on convertible senior notes |
|
|
377 |
|
|
|
5,780 |
|
Interest accrual on finance lease liabilities |
|
|
22 |
|
|
|
3,244 |
|
Rent expense less than payments |
|
|
(54 |
) |
|
|
(27 |
) |
Change in fair value of contingently returnable assets |
|
|
(719 |
) |
|
|
– |
|
Non-cash accretion income from investments |
|
|
29 |
|
|
|
506 |
|
Impairment or loss on disposal of right-of-use assets and
property and equipment |
|
|
1,769 |
|
|
|
4,048 |
|
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
|
Accounts receivable, net |
|
|
(5,851 |
) |
|
|
1,354 |
|
Accrued interest on investments |
|
|
284 |
|
|
|
(101 |
) |
Contract, prepaid and other current assets |
|
|
4,016 |
|
|
|
2,410 |
|
Deferred costs and other non-current assets |
|
|
1,582 |
|
|
|
1,249 |
|
Accounts payable and accrued expenses |
|
|
(6,025 |
) |
|
|
3,520 |
|
Accrued compensation and benefits |
|
|
(4,853 |
) |
|
|
(4,907 |
) |
Deferred revenue |
|
|
139 |
|
|
|
(615 |
) |
Other non-current liabilities |
|
|
60 |
|
|
|
159 |
|
Net cash (used in) provided by
operating activities |
|
|
(3,699 |
) |
|
|
17,927 |
|
Cash flows from
investing activities |
|
|
|
|
|
|
|
|
Purchases of investments held-to-maturity |
|
|
– |
|
|
|
(48,427 |
) |
Proceeds from short-term investments held-to-maturity |
|
|
– |
|
|
|
48,000 |
|
Maturities of investments available-for-sale |
|
|
22,045 |
|
|
|
– |
|
Sales of investments available-for-sale |
|
|
14,691 |
|
|
|
– |
|
Business combination, net of cash acquired |
|
|
(500 |
) |
|
|
– |
|
Purchases of property and equipment |
|
|
(3,911 |
) |
|
|
(4,483 |
) |
Net cash provided by (used in)
investing activities |
|
|
32,325 |
|
|
|
(4,910 |
) |
Cash flows from
financing activities |
|
|
|
|
|
|
|
|
Payments of preferred dividends |
|
|
(3,200 |
) |
|
|
(3,200 |
) |
Payments of contingent consideration |
|
|
(675 |
) |
|
|
– |
|
Proceeds from exercises of stock options and ESPP |
|
|
– |
|
|
|
322 |
|
Payments on financing obligations |
|
|
(2 |
) |
|
|
(224 |
) |
Payments of principal on finance lease liabilities |
|
|
(4,253 |
) |
|
|
(2,559 |
) |
Net cash used in financing
activities |
|
|
(8,130 |
) |
|
|
(5,661 |
) |
Net increase in cash
and cash equivalents |
|
|
20,496 |
|
|
|
7,356 |
|
Cash and cash equivalents,
beginning of period |
|
|
31,001 |
|
|
|
90,706 |
|
Cash and cash
equivalents, end of period |
|
$ |
51,497 |
|
|
$ |
98,062 |
|
|
|
|
|
|
|
|
|
|
Supplemental
disclosure of non-cash investing and financing
activities |
|
|
|
|
|
|
|
|
Property and equipment purchases in accounts payable and accrued
expenses |
|
$ |
52 |
|
|
$ |
– |
|
|
|
|
|
|
|
|
|
|
Benefitfocus, Inc.Unaudited Reconciliation of GAAP
to Non-GAAP Measures(in thousands, except share and per share
data) |
|
|
|
Three Months EndedJune 30, |
|
|
Six Months EndedJune 30, |
|
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
Reconciliation from Gross Profit to Non-GAAP Gross
Profit: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
$ |
27,492 |
|
|
$ |
32,874 |
|
|
$ |
58,831 |
|
|
$ |
69,344 |
|
Amortization of acquired intangible assets |
|
|
610 |
|
|
|
336 |
|
|
|
1,232 |
|
|
|
673 |
|
Stock-based compensation expense |
|
|
1,008 |
|
|
|
638 |
|
|
|
1,204 |
|
|
|
964 |
|
Total net adjustments |
|
|
1,618 |
|
|
|
974 |
|
|
|
2,436 |
|
|
|
1,637 |
|
Non-GAAP gross profit |
|
$ |
29,110 |
|
|
$ |
33,848 |
|
|
$ |
61,267 |
|
|
$ |
70,981 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation from Operating Loss to Non-GAAP Operating
Income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating loss |
|
$ |
(9,967 |
) |
|
$ |
(9,451 |
) |
|
$ |
(10,004 |
) |
|
$ |
(5,966 |
) |
Amortization of acquired intangible assets |
|
|
1,073 |
|
|
|
569 |
|
|
|
2,146 |
|
|
|
1,137 |
|
Stock-based compensation expense |
|
|
5,315 |
|
|
|
4,376 |
|
|
|
6,504 |
|
|
|
5,899 |
|
Transaction and acquisition-related costs expensed |
|
|
13 |
|
|
|
6 |
|
|
|
96 |
|
|
|
160 |
|
Impairment of lease right-of-use assets |
|
|
1,769 |
|
|
|
4,003 |
|
|
|
1,769 |
|
|
|
4,003 |
|
Change in fair value of contingently returnable consideration |
|
|
(719 |
) |
|
|
— |
|
|
|
(719 |
) |
|
|
— |
|
Costs not core to our business |
|
|
2,800 |
|
|
|
1,717 |
|
|
|
4,755 |
|
|
|
3,598 |
|
Total net adjustments |
|
|
10,251 |
|
|
|
10,671 |
|
|
|
14,551 |
|
|
|
14,797 |
|
Non-GAAP operating income |
|
$ |
284 |
|
|
$ |
1,220 |
|
|
$ |
4,547 |
|
|
$ |
8,831 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation from Net Loss to Adjusted
EBITDA: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(12,164 |
) |
|
$ |
(15,020 |
) |
|
$ |
(14,441 |
) |
|
$ |
(17,117 |
) |
Depreciation |
|
|
3,264 |
|
|
|
3,444 |
|
|
|
6,498 |
|
|
|
7,067 |
|
Amortization of software development costs |
|
|
2,388 |
|
|
|
2,159 |
|
|
|
4,818 |
|
|
|
4,321 |
|
Amortization of acquired intangible assets |
|
|
1,073 |
|
|
|
569 |
|
|
|
2,146 |
|
|
|
1,137 |
|
Interest income |
|
|
(72 |
) |
|
|
(54 |
) |
|
|
(84 |
) |
|
|
(111 |
) |
Interest expense |
|
|
2,476 |
|
|
|
5,646 |
|
|
|
4,958 |
|
|
|
11,201 |
|
Income tax expense |
|
|
29 |
|
|
|
41 |
|
|
|
45 |
|
|
|
83 |
|
Stock-based compensation expense |
|
|
5,315 |
|
|
|
4,376 |
|
|
|
6,504 |
|
|
|
5,899 |
|
Transaction and acquisition-related costs expensed |
|
|
13 |
|
|
|
6 |
|
|
|
96 |
|
|
|
160 |
|
Impairment of lease right-of-use assets |
|
|
1,769 |
|
|
|
4,003 |
|
|
|
1,769 |
|
|
|
4,003 |
|
Change in fair value of contingently returnable consideration |
|
|
(719 |
) |
|
|
— |
|
|
|
(719 |
) |
|
|
— |
|
Restructuring costs |
|
|
— |
|
|
|
2,727 |
|
|
|
1,006 |
|
|
|
4,127 |
|
Costs not core to our business |
|
|
2,800 |
|
|
|
1,717 |
|
|
|
4,755 |
|
|
|
3,598 |
|
Total net adjustments |
|
|
18,336 |
|
|
|
24,634 |
|
|
|
31,792 |
|
|
|
41,485 |
|
Adjusted EBITDA |
|
$ |
6,172 |
|
|
$ |
9,614 |
|
|
$ |
17,351 |
|
|
$ |
24,368 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation from Net Loss to Non-GAAP Net (Loss)
Income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(12,164 |
) |
|
$ |
(15,020 |
) |
|
$ |
(14,441 |
) |
|
$ |
(17,117 |
) |
Amortization of acquired intangible assets |
|
|
1,073 |
|
|
|
569 |
|
|
|
2,146 |
|
|
|
1,137 |
|
Stock-based compensation expense |
|
|
5,315 |
|
|
|
4,376 |
|
|
|
6,504 |
|
|
|
5,899 |
|
Transaction and acquisition-related costs expensed |
|
|
13 |
|
|
|
6 |
|
|
|
96 |
|
|
|
160 |
|
Impairment of lease right-of-use assets |
|
|
1,769 |
|
|
|
4,003 |
|
|
|
1,769 |
|
|
|
4,003 |
|
Change in fair value of contingently returnable consideration |
|
|
(719 |
) |
|
|
— |
|
|
|
(719 |
) |
|
|
— |
|
Costs not core to our business |
|
|
2,800 |
|
|
|
1,717 |
|
|
|
4,755 |
|
|
|
3,598 |
|
Total net adjustments |
|
|
10,251 |
|
|
|
10,671 |
|
|
|
14,551 |
|
|
|
14,797 |
|
Non-GAAP net (loss) income |
|
$ |
(1,913 |
) |
|
$ |
(4,349 |
) |
|
$ |
110 |
|
|
$ |
(2,320 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Calculation of Non-GAAP Earnings Per Share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP net (loss) income |
|
$ |
(1,913 |
) |
|
$ |
(4,349 |
) |
|
$ |
110 |
|
|
$ |
(2,320 |
) |
Preferred dividends |
|
|
(1,600 |
) |
|
|
(1,600 |
) |
|
|
(3,200 |
) |
|
|
(3,200 |
) |
Non-GAAP net loss available to common stockholders |
|
$ |
(3,513 |
) |
|
$ |
(5,949 |
) |
|
$ |
(3,090 |
) |
|
$ |
(5,520 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding - basic and diluted |
|
|
34,028,422 |
|
|
|
33,080,257 |
|
|
|
33,764,103 |
|
|
|
32,787,162 |
|
Shares used in computing non-GAAP net loss per share - basic and
diluted |
|
|
34,028,422 |
|
|
|
33,080,257 |
|
|
|
33,764,103 |
|
|
|
32,787,162 |
|
Non-GAAP net loss per common share - basic and diluted |
|
$ |
(0.10 |
) |
|
$ |
(0.18 |
) |
|
$ |
(0.09 |
) |
|
$ |
(0.17 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of Cash Flows from Operations to Free Cash
Flow: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash and cash equivalents (used in) provided by operating
activities |
|
$ |
(699 |
) |
|
$ |
9,163 |
|
|
$ |
(3,699 |
) |
|
$ |
17,927 |
|
Purchases of property and equipment |
|
|
(1,901 |
) |
|
|
(2,590 |
) |
|
|
(3,911 |
) |
|
|
(4,483 |
) |
Cash paid for restructuring costs |
|
|
518 |
|
|
|
5 |
|
|
|
1,304 |
|
|
|
1,384 |
|
Total net adjustments |
|
|
(1,383 |
) |
|
|
(2,585 |
) |
|
|
(2,607 |
) |
|
|
(3,099 |
) |
Free Cash Flow |
|
$ |
(2,082 |
) |
|
$ |
6,578 |
|
|
$ |
(6,306 |
) |
|
$ |
14,828 |
|
Benefitfocus (NASDAQ:BNFT)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Benefitfocus (NASDAQ:BNFT)
Historical Stock Chart
Von Apr 2023 bis Apr 2024